Rachna Shroff, MD, led a landmark study on the use of targeted drugs called PARP inhibitors in pancreatic cancer patients with BRCA mutations.

Designer antibodies, such as checkpoint inhibitors, have revolutionized cancer treatment.

Joint statement empowers parents, young adults and physicians to increase vaccination rates and screenings to eliminate HPV-related cancers, starting with cervical cancer.